Antimicrobial Therapy for Infections Caused by Carbapenem-Resistant Gram-Negative Bacteria / 대한내과학회지
Korean Journal of Medicine
;
: 439-446, 2018.
Article
in Korean
| WPRIM
| ID: wpr-717699
ABSTRACT
Carbapenem-resistance emerging in Gram-negative pathogens, such as Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii, has become a major human health problem globally. The therapeutic options available for carbapenem-resistant pathogens are very limited. Antibiotics such as colistin, tigecycline, fosfomycin, and aminoglycosides are often the only ones that can be used to treat carbapenem-resistant pathogens. Carbapenem may still be an option in certain circumstances. The administration of combination therapy for carbapenem-resistant pathogens is controversial. This review presents the current knowledge of available antimicrobial therapeutic options for infections due to carbapenem-resistant pathogens in Korea.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Pseudomonas aeruginosa
/
Drug Resistance
/
Treatment Outcome
/
Colistin
/
Acinetobacter baumannii
/
Fosfomycin
/
Gram-Negative Bacteria
/
Aminoglycosides
/
Klebsiella pneumoniae
/
Korea
Limits:
Humans
Country/Region as subject:
Asia
Language:
Korean
Journal:
Korean Journal of Medicine
Year:
2018
Type:
Article
Similar
MEDLINE
...
LILACS
LIS